[1]
Migden, M., Guminski, A., Gutzmer, R., Loquai, C., Squittieri, N. and Foley, P. 2023. Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s180. DOI:https://doi.org/10.25251/skin.7.supp.180.